Updated Aug 18 at 11:32am ET.
Follow Travelers to never miss an important update.
Travelers issued a formal filing to report a change in its executive team or board of directors. These filings are required when a high-level leader joins, leaves, or changes roles within the company.
While the specific name was not detailed in the initial notice, leadership changes at this level are important for long-term owners to track. A smooth transition is key for a company that relies on strict underwriting discipline, the practice of carefully choosing which risks to insure and at what price, to maintain its profit margins.
Source: 8-K filing
Yields on 30-year Treasury bonds, which are the interest rates the government pays to borrow money for three decades, have climbed back to levels not seen in nearly twenty years. This move was driven by a stronger-than-expected manufacturing report and rising oil prices.
For an insurer like Travelers, higher rates are a major advantage. The company manages a $90 billion investment portfolio, mostly made up of safe bonds. As older bonds in that portfolio mature, Travelers can reinvest that cash into these new, higher-yielding bonds. This process steadily increases its net investment income, which is the profit it earns simply by holding and managing its customers' premiums before they are paid out as claims.
Source: Bloomberg Markets and Finance
The company has finished the 50-state rollout of its Synergy product, which covers life sciences firms against claims related to their products. This insurance protects companies from the research phase through manufacturing. Expanding into California is a logical step given the state's large concentration of biotech and medical device firms. While this is a niche market, it shows the company is using its scale to offer specialized policies that are harder for smaller competitors to price accurately.
Source: Business Wire
AM Best, a firm that specializes in grading the financial health of insurance companies, assigned an a+ rating to the company's new $750 million in debt. This high grade suggests the company is in a strong position to pay back what it borrows. The money will be used for general business needs. With a debt-to-capital ratio of about 21 percent, the company is keeping its borrowing at a level that is manageable and typical for a large insurer.
Source: Business Wire
BMO Capital lowered its rating on the stock to Market Perform, which is their way of saying they expect it to perform about the same as the rest of the market. This move comes even after the company reported very strong quarterly results. The analysts set a price target of $379, which is close to where the stock is currently trading. This suggests they believe the recent good news is already reflected in the stock price, leaving less room for it to rise much further in the near term.
Source: BMO Capital
Analysts issued a flurry of downgrades throughout July as they adjusted their outlooks. Only 11 of 44 analysts recommend buying the stock, and the average price target of $351 is 5% below the current price.
The company has a perfect record of beating analyst profit targets over the last two years. Management consistently delivers much higher earnings than the market expects, showing they have a very firm grip on their costs.
| Expectation | |
|---|---|
| EPS | $6.77 |
| Revenue | $11.31B |
